2nd International Conference on Chemo and Bioinformatics ICCBIKG 2023 (411-414)
АУТОР(И) / AUTHOR(S): Snežana Jovanović Stević, Snežana Radisavljević, Aleksandar Mijatović, Biljana Petrović, Ana Kesić
Е-АДРЕСА / E-MAIL: snezanaj@kg.ac.rs
DOI: 10.46793/ICCBI23.411JS
САЖЕТАК / ABSTRACT:
This mini-review summarizes the kinetic data obtained for the substitution reactions of some palladium(II) complexes containing bis-pyrazolylpyridine derivatives as pincer-type ligands with biologically significant nitrogen- and sulfur-donor biomolecules as nucleophiles. Three structurally different palladium(II) complexes were selected: [Pd(L1)Cl]+(Pd1), [Pd(L2)Cl]+(Pd2) and [Pd(L3)Cl]+(Pd3) (where L1 = bis(2-(1H-pyrazol-1-yl)ethyl)amine, L2 = 2,6-bis(5-(tert-butyl)-1H-pyrazol-3-yl)pyridine, and L3 = 2,6-bis(5-(tert-butyl)-1-methyl-1H-pyrazol-3-yl)pyridine, while for the entering nucleophiles thiourea (Tu), L-methionine (L-met), and guanosine-5’-monophosphate (5’-GMP) were used. Kinetic measurements were carried out for all systems as pseudo-first order reactions (at least 10 times the ligand in excess relative to the complex) under physiological conditions using a stopped-flow UV-Vis spectrophotometer. By comparing the published results for the second-order rate constant, the relationship between the structural properties of the complexes and their reactivity towards selected nucleophiles was established. This overview shows that by tuning the lability of the inert ligands through steric and electronic (σ-donor and π-acceptor) effects, the biological behavior of the complexes can be significantly changed.
КЉУЧНЕ РЕЧИ / KEYWORDS:
Pd(II), structural modification, kinetics
ЛИТЕРАТУРА / REFERENCES:
- U. Ndagi, N. Mhlongo, M.E. Soliman, Metal complexes in cancer therapy – an update from drug design perspective, Drug Design, Development and Therapy, 11 (2017) 599-616.
- M. Fanelli, M. Formica, V. Fusi, L. Giorgi, M. Micheloni, P. Paoli, New trends in platinum and palladium complexes as antineoplastic agents, Coordination Chemistry Reviews, 310 (2016) 41-79.
- N.P. Farell, Multi-platinum anti-cancer agents. Substitution-inert compounds for tumor selectivity and new targets, Chemical Society Reviews, 44 (2015) 8773-8785.
- Ž.D. Bugarčić, J. Bogojeski, R. van Eldik, Kinetics, mechanism and equilibrium studies on the substitution reactions of Pd(II) in reference to Pt(II) complexes with bio-molecules, Coordination Chemistry Reviews, 292 (2015) 91-106.
- A.R. Kapdi, I.J.S. Fairlamb, Anti-cancer palladium complexes: a focus on PdX2L2, palladacycles and related complexes, Chemical Society Reviews, 43 (2014) 4751–4777.
- B. Petrović, S. Jovanović, R. Puchta, R. van Eldik, Mechanistic insight on the chemistry of potential Pt antitumor agents as revealed by collaborative research performed in Kragujevac and Erlangen, Inorganica Chimica Acta 495 (2019) 118953.
- R.O. Omondi, A.O. Fadaka, A.A. Fatoku, D. Jaganyi, S.O. Ojwach, Synthesis, substitution kinetics, DNA/BSA binding and cytotoxicity of tridentate N^E^N (E=NH, O, S) pyrazolyl palladium(II) complexes, Journal of Biological inorganic chemistr, 27 (2022) 653-664.
- D. Ćoćić, S. Jovanović, S. Radisavljević, J. Korzekwa, A. Scheurer, R. Puchta, D. Baskić, D. Todorović, S. Popović, S. Matić, B. Petrović, New monofunctional platinum(II) and palladium(II) complexes: Studies of the nucleophilic substitution reactions, DNA/BSA interaction, and cytotoxic activity, Journal of Inorganic Biochemistry, 189 (2018) 91-102.